TAK - Blackstone Weighs Sale Of Japanese Pharma Firm Alinamin: Report | Benzinga
Blackstone Inc. (NYSE:BX) is reportedly considering selling the Japanese consumer healthcare firm Alinamin Pharmaceutical Co., previously owned by Takeda Pharmaceutical Company Limited (NYSE:TAK).
Blackstone is collaborating with financial advisers on a potential sale of Tokyo-based Alinamin, which could be valued at approximately ¥300 billion ($1.9 billion), reported Bloomberg, citing sources.
According to the report, Alinamin is ...